Hassan MM - Search Results

1

Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study.

Hassan MM, Spitz MR, Thomas MB, El-Deeb AS, Glover KY, Nguyen NT, Chan W, Kaseb A, Curley SA, Vauthey JN, Ellis LM, Abdalla E, Lozano RD, Patt YZ, Brown TD, Abbruzzese JL, Li D. Hassan MM, et al. Int J Cancer. 2008 Oct 15;123(8):1883-91. doi: 10.1002/ijc.23730. Int J Cancer. 2008. PMID: 18688864 Free PMC article.

2

Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinoma.

Wu X, Gu J, Patt Y, Hassan M, Spitz MR, Beasley RP, Hwang LY. Wu X, et al. Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):567-70. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9681523

3

Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide.

Patt YZ, Hassan MM, Lozano RD, Ellis LM, Peterson JA, Waugh KA. Patt YZ, et al. Among authors: hassan mm. Am J Clin Oncol. 2000 Jun;23(3):319-21. doi: 10.1097/00000421-200006000-00023. Am J Clin Oncol. 2000. PMID: 10857902

4

The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients.

Hassan MM, Zaghloul AS, El-Serag HB, Soliman O, Patt YZ, Chappell CL, Beasley RP, Hwang LY. Hassan MM, et al. J Clin Gastroenterol. 2001 Aug;33(2):123-6. doi: 10.1097/00004836-200108000-00006. J Clin Gastroenterol. 2001. PMID: 11468438

5

Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.

Patt YZ, Hassan MM, Lozano RD, Waugh KA, Hoque AM, Frome AI, Lahoti S, Ellis L, Vauthey JN, Curley SA, Schnirer II, Raijman I. Patt YZ, et al. Among authors: hassan mm. Clin Cancer Res. 2001 Nov;7(11):3375-80. Clin Cancer Res. 2001. PMID: 11705850 Clinical Trial.

6

DNA adducts, genetic polymorphisms, and K-ras mutation in human pancreatic cancer.

Li D, Firozi PF, Zhang W, Shen J, DiGiovanni J, Lau S, Evans D, Friess H, Hassan M, Abbruzzese JL. Li D, et al. Mutat Res. 2002 Jan 15;513(1-2):37-48. doi: 10.1016/s1383-5718(01)00291-1. Mutat Res. 2002. PMID: 11719088

7

Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.

Firozi PF, Bondy ML, Sahin AA, Chang P, Lukmanji F, Singletary ES, Hassan MM, Li D. Firozi PF, et al. Among authors: hassan mm. Carcinogenesis. 2002 Feb;23(2):301-6. doi: 10.1093/carcin/23.2.301. Carcinogenesis. 2002. PMID: 11872636

8

Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States.

Hassan MM, Frome A, Patt YZ, El-Serag HB. Hassan MM, et al. J Clin Gastroenterol. 2002 Sep;35(3):266-9. doi: 10.1097/00004836-200209000-00013. J Clin Gastroenterol. 2002. PMID: 12192205

9

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.

Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Hassan MM, et al. Hepatology. 2002 Nov;36(5):1206-13. doi: 10.1053/jhep.2002.36780. Hepatology. 2002. PMID: 12395331

10

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.

Patt YZ, Hassan MM, Lozano RD, Brown TD, Vauthey JN, Curley SA, Ellis LM. Patt YZ, et al. Among authors: hassan mm. J Clin Oncol. 2003 Feb 1;21(3):421-7. doi: 10.1200/JCO.2003.10.103. J Clin Oncol. 2003. PMID: 12560429 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

785 results

Search Page

Filters